Surgecare

Surge develops PreCyte, an immune-based diagnostic approach to identify patients at risk of postoperative complications and support smarter discharge and care pathways. PreCyte focuses on immune signatures associated with surgical site infection and pulmonary complications, helping care teams intervene earlier and allocate resources more effectively. Use cases - Postoperative risk stratification for surgical site infection and pulmonary complications - Support for discharge timing and pathway optimization in perioperative care - Immune profiling to inform patient monitoring and follow-up decisions Proof points - Early clinical deployments with leading academic medical centers - Built on more than a decade of translational immunology and multi-omics research - Developed with a strong focus on quality, clinical proofpoints, and technological breakthroughs